FDA has begun an initiative to verify facility information that has been provided to FDA including, but not limited to, facilities’ DUNS numbers, addresses, and products. FDA has retained the services of Dun & Bradstreet to carry out this onsite facility verification. In conjunction with this initiative, firms registered with FDA, or of which FDA is otherwise aware, may expect to be contacted by Dun & Bradstreet personnel.
Although there is no legal requirement for firms to do so, if your facility is contacted, we ask for your full cooperation with Dun & Bradstreet in connection with this important undertaking. If your firm is contacted and you want to confirm the legitimacy of the verification request, please ask to see the requestor’s Dun & Bradstreet identification.
Additionally, if your firm has general questions regarding this initiative, please email the Office of International Programs team at FDACSI@fda.hhs.gov, using the subject line 'Dun & Bradstreet'.